Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits.
about
C-reactive protein and coronary heart disease: all said--is not it?Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammationImmunity, atherosclerosis and cardiovascular diseaseProtective effects of methotrexate against ischemic cardiovascular disorders in patients treated for rheumatoid arthritis or psoriasis: novel therapeutic insights coming from a meta-analysis of the literature data.Anti-inflammatory therapies for cardiovascular diseaseInnate and Adaptive Immunity in Calcific Aortic Valve DiseaseInflammation as a Risk of Developing Chronic Kidney Disease in Rheumatoid Arthritis.Atherosclerosis and rheumatoid arthritis: more than a simple association.Cardiovascular risk in pediatric-onset rheumatological diseases.Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles.Combination with methotrexate and cyclophosphamide attenuated maturation of dendritic cells: inducing Treg skewing and Th17 suppression in vivo.Immune mechanisms in atherosclerosis, especially in diabetes type 2Moving beyond JUPITER: will inhibiting inflammation reduce vascular event rates?Leukocyte trafficking-associated vascular adhesion protein 1 is expressed and functionally active in atherosclerotic plaques.Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis.High cholesterol diet effects on ischemia-reperfusion injury of the heart.Breakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems.Targeting inflammation: impact on atherothrombosis.Inflammation and cardiovascular disease: from pathogenesis to therapeutic target.Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease.Prediction and management of cardiovascular outcomes in systemic lupus erythematosus.Advances in non-invasive drug delivery for atherosclerotic heart disease.MethotrexaTE THerapy in ST-Segment Elevation MYocardial InfarctionS.Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.Inflammatory processes in cardiovascular disease: a route to targeted therapies.Plaque Rupture and Thrombosis: the Value of the Atherosclerotic Rabbit Model in Defining the Mechanism.Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?Immune-mediated mechanisms of atherosclerosis and implications for the clinic.Use of combined chemotherapy with etoposide and methotrexate, both associated to lipid nanoemulsions for atherosclerosis treatment in cholesterol-fed rabbits.Inflammation and atherosclerosis: disease modulating therapies.Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis.Targeting inflammatory pathways for the treatment of cardiovascular disease.Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits.Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study.Comparison of 68Ga-DOTA-Siglec-9 and 18F-Fluorodeoxyribose-Siglec-9: Inflammation Imaging and Radiation Dosimetry.Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence.Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk.Methotraxate-Loaded Hybrid Nanoconstructs Target Vascular Lesions and Inhibit Atherosclerosis Progression in ApoE-/- Mice.Lipid core nanoparticles resembling low-density lipoprotein and regression of atherosclerotic lesions: effects of particle size.Analysis of Drug Effects on Primary Human Coronary Artery Endothelial Cells Activated by Serum Amyloid A.
P2860
Q26860959-FB3D0C76-AD95-4339-8E0E-715D0571BFB6Q27320563-9192CB4F-4F0D-4511-B609-0972603ACBB3Q28688590-FE6839B9-ED16-4760-B8B5-653AFC0446BFQ31005025-A101EE48-30C9-4E2A-8492-F3103234285EQ34137872-B41CE47B-A959-41D9-8465-5AFB802F9251Q35612638-BEAB20A1-7739-46E5-8FA4-BA3296FF6403Q36106803-63DE4DA2-72C9-4F67-B21F-8BFEAECBDA6DQ36253671-994C45EB-C255-48CB-9E04-6CB9F2FAB334Q36903089-D2FF2BA0-4E78-4028-82F3-746D3ABA4FD4Q37156203-6684FE91-FD3F-4670-B08F-9E0F559D4B4DQ37249844-53E43533-4D73-4769-AC7E-F1AB6B00BB99Q37261617-8D7BFD30-08E3-4713-9386-96CF0CE498ECQ37279687-F96B41D2-87B7-4049-AC17-2F91234BB1BEQ37330522-F97AEFC5-78F9-424E-87A0-74DF23CD2AEDQ37466366-4CDE6C22-E4C2-4E45-B538-7ADC79FD7687Q38036707-B08CDADC-143A-46AF-8B75-EB7E7DA61130Q38168361-49FDAE62-4391-470A-B1D4-17A564EBEA3CQ38170328-A5D544FD-D0A6-4127-B426-EAFD8B54986EQ38231099-0C5DA967-59B0-413F-BD7F-7BE19E4A8615Q38265002-8FF02CFC-E658-4297-81E1-25E67C53BB6DQ38291820-8614006B-CCF9-4041-AA3E-C0E6FD492612Q38317205-6FADC9BD-3B79-461C-BF5C-F292B49789EFQ38379218-5FAAA6FE-B496-408C-A35F-CE27224A214BQ38786058-3AC60B9E-EE26-43C7-9361-0604CA9424D6Q38788685-6747ECAA-EA73-480B-AF14-4597452CB4DBQ38811419-20B9F4AF-7908-48C9-8C35-ED86A1BD99DCQ38836998-FF8E9B46-C36C-47FA-957B-ADE0C2AB55C1Q38851472-C136F3D1-9C5E-494D-AA90-9558B92FCCE1Q39040956-2D4D2488-F79A-48EB-A5A6-218203D4FC5AQ39360950-217AF022-71ED-46C6-9538-3102E46C40C6Q39461770-903A3CB3-6023-4A75-8549-574539A47A37Q42410556-35961BFC-4F17-4BEF-AE81-E7132F83CFD4Q42709233-1BF4B61C-A454-493A-8F31-937FA5CBA1C3Q45077865-DD8FF952-4249-4A49-BCC7-CAA2602B90FEQ49788469-91D53087-3229-45D1-8789-E019652615EBQ50074049-956E92EF-DD86-48E8-A73C-13D80A7A2C4CQ50233845-6C56E835-C904-4C32-B94A-912409724D35Q50659065-1057A8F0-BC15-4F67-A80D-808767CEB22EQ51743444-6E57860C-82E7-4A37-8432-01359C27D118Q55008598-D724BC60-90BA-47EB-90B1-D91784CE96CC
P2860
Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits.
@en
Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits.
@nl
type
label
Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits.
@en
Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits.
@nl
prefLabel
Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits.
@en
Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits.
@nl
P2093
P1476
Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits.
@en
P2093
Adriana Abalen Martins Dias
Adriana Bulgarelli
Bruno Caramelli
P304
P356
10.1097/FJC.0B013E318241C385
P407
P577
2012-04-01T00:00:00Z